- Home
- GALT vs LOVE Comparison
GALT vs LOVE Comparison
Compare GALT & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- LOVE
- Stock Information
- Founded
- GALT 2000
- LOVE 1998
- Country
- GALT United States
- LOVE United States
- Employees
- GALT N/A
- LOVE N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- LOVE Other Specialty Stores
- Sector
- GALT Health Care
- LOVE Consumer Discretionary
- Exchange
- GALT Nasdaq
- LOVE Nasdaq
- Market Cap
- GALT 232.3M
- LOVE 209.8M
- IPO Year
- GALT N/A
- LOVE 2018
- Fundamental
- Price
- GALT $5.67
- LOVE $13.61
- Analyst Decision
- GALT Strong Buy
- LOVE Strong Buy
- Analyst Count
- GALT 3
- LOVE 5
- Target Price
- GALT $6.00
- LOVE $30.00
- AVG Volume (30 Days)
- GALT 339.7K
- LOVE 556.7K
- Earning Date
- GALT 11-14-2025
- LOVE 12-11-2025
- Dividend Yield
- GALT N/A
- LOVE N/A
- EPS Growth
- GALT N/A
- LOVE 33.72
- EPS
- GALT N/A
- LOVE 0.79
- Revenue
- GALT N/A
- LOVE $690,298,000.00
- Revenue This Year
- GALT N/A
- LOVE $6.93
- Revenue Next Year
- GALT N/A
- LOVE $7.52
- P/E Ratio
- GALT N/A
- LOVE $17.25
- Revenue Growth
- GALT N/A
- LOVE N/A
- 52 Week Low
- GALT $0.73
- LOVE $12.12
- 52 Week High
- GALT $6.55
- LOVE $39.49
- Technical
- Relative Strength Index (RSI)
- GALT 62.88
- LOVE 31.49
- Support Level
- GALT $5.04
- LOVE $14.63
- Resistance Level
- GALT $5.36
- LOVE $14.03
- Average True Range (ATR)
- GALT 0.33
- LOVE 0.53
- MACD
- GALT 0.05
- LOVE -0.00
- Stochastic Oscillator
- GALT 60.81
- LOVE 7.89
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.